Literature DB >> 22543925

Pathogenesis of Paget disease of bone.

Stuart H Ralston1, Rob Layfield.   

Abstract

Paget disease of bone (PDB) is a common disease characterized by focal areas of increased and disorganized bone turnover. Some patients are asymptomatic, whereas others develop complications such as pain, osteoarthritis, fracture, deformity, deafness, and nerve compression syndromes. PDB is primarily caused by dysregulation of osteoclast differentiation and function, and there is increasing evidence that this is due, in part, to genetic factors. One of the most important predisposing genes is SQSTM1, which harbors mutations that cause osteoclast activation in 5-20 % of PDB patients. Seven additional susceptibility loci for PDB have been identified by genomewide association studies on chromosomes 1p13, 7q33, 8q22, 10p13, 14q32, 15q24, and 18q21. Although the causal variants remain to be discovered, three of these loci contain CSF1, TNFRSF11A, and TM7SF4, genes that are known to play a critical role in osteoclast differentiation and function. Environmental factors are also important in the pathogenesis of PDB, as reflected by the fact that in many countries the disease has become less common and less severe over recent years. The most widely studied environmental trigger is paramyxovirus infection, but attempts to detect viral transcripts in tissues from patients with PDB have yielded mixed results. Although our understanding of the pathophysiology of PDB has advanced tremendously over the past 10 years, many questions remain unanswered, such as the mechanisms responsible for the focal nature of the disease and the recent changes in prevalence and severity.

Entities:  

Mesh:

Year:  2012        PMID: 22543925     DOI: 10.1007/s00223-012-9599-0

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  35 in total

1.  The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget's Disease in a United States Cohort.

Authors:  Margaret Seton; Marc Hansen; Daniel H Solomon
Journal:  Calcif Tissue Int       Date:  2015-12-28       Impact factor: 4.333

2.  Biallelic SQSTM1 mutations in early-onset, variably progressive neurodegeneration.

Authors:  Valentina Muto; Elisabetta Flex; Zachary Kupchinsky; Guido Primiano; Hamid Galehdari; Mohammadreza Dehghani; Serena Cecchetti; Giovanna Carpentieri; Teresa Rizza; Neda Mazaheri; Alireza Sedaghat; Mohammad Yahya Vahidi Mehrjardi; Alice Traversa; Michela Di Nottia; Maria M Kousi; Yalda Jamshidi; Andrea Ciolfi; Viviana Caputo; Reza Azizi Malamiri; Francesca Pantaleoni; Simone Martinelli; Aaron R Jeffries; Jawaher Zeighami; Amir Sherafat; Daniela Di Giuda; Gholam Reza Shariati; Rosalba Carrozzo; Nicholas Katsanis; Reza Maroofian; Serenella Servidei; Marco Tartaglia
Journal:  Neurology       Date:  2018-06-29       Impact factor: 9.910

3.  Clinical efficacy of oral risedronate therapy in Japanese patients with Paget's disease of bone.

Authors:  Masaya Ohara; Yasuo Imanishi; Yuki Nagata; Akira Ishii; Ikue Kobayashi; Katsuhito Mori; Manabu Ito; Takami Miki; Yoshiki Nishizawa; Masaaki Inaba
Journal:  J Bone Miner Metab       Date:  2014-10-16       Impact factor: 2.626

4.  Paget's sarcoma of the patella.

Authors:  Salman Ansari; Fiona Bonar; Paul Stalley; Wendy Brown
Journal:  Skeletal Radiol       Date:  2015-04-12       Impact factor: 2.199

5.  Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease.

Authors:  Katrina J Llewellyn; Angèle Nalbandian; Kwang-Mook Jung; Christopher Nguyen; Agnesa Avanesian; Tahseen Mozaffar; Daniele Piomelli; Virginia E Kimonis
Journal:  Hum Mol Genet       Date:  2013-10-24       Impact factor: 6.150

6.  VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone.

Authors:  Ricardo Usategui-Martín; Ismael Calero-Paniagua; Judith García-Aparicio; Luis Corral-Gudino; Javier Del Pino Montes; Rogelio González Sarmiento
Journal:  Genet Test Mol Biomarkers       Date:  2016-05-12

Review 7.  Paget's Disease of Bone: Osteoimmunology and Osteoclast Pathology.

Authors:  Emily M Rabjohns; Katlyn Hurst; Arin Ghosh; Maria C Cuellar; Rishi R Rampersad; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-25       Impact factor: 4.806

8.  The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway.

Authors:  Hye Jung Ihn; Doohyun Lee; Taeho Lee; Hong-In Shin; Yong Chul Bae; Sang-Hyun Kim; Eui Kyun Park
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

9.  Paget's disease population analysis within Rheumatology Outpatient of the ASL of Biella (Piedmont Region, Italy).

Authors:  Lorena Longato
Journal:  Clin Cases Miner Bone Metab       Date:  2014-01

Review 10.  Dental Manifestations of Pediatric Bone Disorders.

Authors:  Juan F Yepes
Journal:  Curr Osteoporos Rep       Date:  2017-12       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.